Our case report may represent a treatment option for patients withtreatment-resistant schizophrenia, who display partial responses to clozapine and face the risk of developing a metabolic syndrome. This effective, though extreme, polypharmacy of treatment-resistant schizophrenia require further evidence and confirmative data and should be used only in severe, selected cases, with the full consent and compliance of patients.
Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.
TOFFANIN, TOMMASO;PERINI, GIULIA
2009
Abstract
Our case report may represent a treatment option for patients withtreatment-resistant schizophrenia, who display partial responses to clozapine and face the risk of developing a metabolic syndrome. This effective, though extreme, polypharmacy of treatment-resistant schizophrenia require further evidence and confirmative data and should be used only in severe, selected cases, with the full consent and compliance of patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pigato, Toffanin and Perini 2009.pdf
Accesso riservato
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso privato - non pubblico
Dimensione
140.22 kB
Formato
Adobe PDF
|
140.22 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
